ReviewCardiology and therapy2019
Complications of Temporary Percutaneous Mechanical Circulatory Support for Cardiogenic Shock: An Appraisal of Contemporary Literature.
Review in Cardiology and therapy, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 67 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
67 citing papers in PubMed, 1 synthesis or guideline pooled it, 140 citations in OpenAlex.
- Reporting of sex as a variable in cardiovascular studies using cultured cells: A systematic review.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2020Pooled it
- Post-Market Analysis of the Xenios Console With the Xlung Tubing Kit 230 for Extracorporeal Membrane Oxygenation After Cardiac Surgery.Artificial organs · 2026Article
- Predictors of Bleeding After Percutaneous Left Ventricular Assist Device Support: Findings From the J-PVAD Registry.JACC. Advances · 2026Article
- A local complication-prevention pathway for Impella-supported cardiogenic shock: a single-center experience.Critical care (London, England) · 2026Article
- Cardiorenal Hemodynamic Coupling: Mechanical Circulatory Support Augments Renal Blood Flow via Renal Vasodilation.JACC. Basic to translational science · 2026Article
- Anticoagulation with bivalirudin is associated with improved biocompatibility in patients supported on microaxial flow pumps.JTCVS open · 2026Article
- Contemporary Mechanical Support Devices for Temporary and Long-Term Applications.Bioengineering (Basel, Switzerland) · 2026Review
- Factors associated with native heart survival and intermediate-term outcomes in acute myocardial infarction-related cardiogenic shock.European heart journal open · 2026Article
- The Role of Impella in Cardiogenic Shock in the Post-DanGer Shock Era.Biomedicines · 2025Review
- Efficacy of a 16 Fr sheath strategy during Impella support to reduce access site bleeding in patients with cardiogenic shock.Heart and vessels · 2025Article
- Advances in Mechanical Circulatory Support (MCS): Literature Review.Biomedicines · 2025Review
- Left Ventricular Mechanical Circulatory Support Devices for Cardiogenic Shock After Myocardial Infarction.Cardiology and therapy · 2025Review
- Outcomes of prolonged support on surgically implanted microaxial left ventricular assist devices for refractory cardiogenic shock.JTCVS open · 2025Article
- Catheter ablation in patients on mechanical circulatory supports for cardiogenic shock.PloS one · 2025Article
- Treatment time limit for successful weaning from veno-arterial extracorporeal membrane oxygenation in cardiogenic shock.ESC heart failure · 2024Article
- Trends and outcomes of different mechanical circulatory support modalities for acute myocardial infarction associated cardiogenic shock in patients undergoing early revascularization.American heart journal plus : cardiology research and practice · 2024Article
- Outcomes of Impella 5.0 and 5.5 for cardiogenic shock: A single-center 137 patient experience.Artificial organs · 2024Article
- Mechanical Circulatory Support Devices in Patients with High-Risk Pulmonary Embolism.Journal of clinical medicine · 2024Review
- Association between Impella device support and elevated rates of gout flares: a retrospective propensity-matched study.BMC rheumatology · 2024Article
- Association of timing of percutaneous left ventricular assist device insertion with outcomes in patients undergoing cardiac surgery.JTCVS open · 2023Article
7 more citing papers are in PubMed but not listed here.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
Abstract
Cardiogenic shock (CS) is associated with hemodynamic compromise and end-organ hypoperfusion due to a primary cardiac etiology. In addition to vasoactive medications, percutaneous mechanical circulatory support (MCS) devices offer the ability to support the hemodynamics and prevent acute organ failure. Despite the wide array of available MCS devices for CS, there are limited data on the complications from these devices. In this review, we seek to summarize the complications of MCS devices in the contemporary era. Using a systems-based approach, this review covers domains of hematological, neurological, vascular, infectious, mechanical, and miscellaneous complications. These data are intended to provide a balanced narrative and aid in risk-benefit decision-making in this acutely ill population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.